Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 -0.01 (-0.85%)
As of: Oct 21, 2026 · 3:08 PM EDT

Chemomab Therapeutics (CMMB) Other Operating Activities (2011 - 2019)

Updated

Analysis

Chemomab Therapeutics (CMMB) Other Operating Activities (2011 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Ops. (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn -291.00 Mn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn -
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn -1.06 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn -
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn -206.00 Mn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn -
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn -
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn -
10 Chemomab Therapeutics 7.46 Mn -27.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 130,000.00
Dec 31, 2018 7,000.00
Dec 31, 2012 -260.39
Sep 30, 2012 -251.53
Dec 31, 2011 55,704.23
Sep 30, 2011 -42,691.07
Jun 30, 2011 39,311.34
API Access

Chemomab Therapeutics Other Operating Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-activities&ticker=CMMB&period=max&api_key=YOUR_API_KEY